An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant

Title
An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant
Authors
Keywords
L38L↑N↑L PR, HIV PR inhibitors, Inhibitor–enzyme interactions, Our own N-layered Integrated molecular orbital and molecular mechanics (ONIOM), Binding free energies, Atoms in molecules (AIM), Natural bond orbital (NBO)
Journal
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
Volume 32, Issue 3, Pages 459-471
Publisher
Springer Nature
Online
2018-02-03
DOI
10.1007/s10822-018-0099-9

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now